Intravenous prostaglandin E1 in severe peripheral vascular disease

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Journal of internal medicine·2017

Macrophage erythrophagocytosis and iron exocytosis.

Redox report : communications in free radical research·2016

HDL and LDL as therapeutic targets for cardiovascular disease prevention: the possible role of niacin.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2010

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.

Journal of internal medicine·2010

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time.

Acta neurologica Scandinavica·2009

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

International journal of clinical practice·2009

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Diversity and taxonomy of Phragmidium on Rosa in China, with descriptions of two new species.

MycoKeys·2026

Achyranthes bidentata polysaccharides alleviate severe traumatic brain injury by suppressing the TLR4/MyD88/NF-κB pathway and inhibiting neutrophil extracellular trap formation.

International immunopharmacology·2026

Multifaceted evaluation of onion bio-actives against Fusarium oxysporum f.sp. Cubense: Bio-efficacy assay, LC-MS metabolomics and in-silico validation.

Computational biology and chemistry·2026

Polygonum cuspidatum Exosome-Like Nanovesicles Alleviate Hypoxic Pulmonary Hypertension by Stabilizing PON1 to Inhibit MAPK-Mediated PASMC Phenotypic Switching.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Correction: Pathogen effector tactics to suppress plant endomembrane system.

Frontiers in plant science·2026

Single-nucleus transcriptomic data of susceptible and resistant tobacco stems after black shank infection.

Data in brief·2026

Related Experiment Videos

Intravenous prostaglandin E1 in severe peripheral vascular disease

Related Concept Videos

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Macrophage erythrophagocytosis and iron exocytosis.

HDL and LDL as therapeutic targets for cardiovascular disease prevention: the possible role of niacin.

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time.

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Diversity and taxonomy of Phragmidium on Rosa in China, with descriptions of two new species.

Achyranthes bidentata polysaccharides alleviate severe traumatic brain injury by suppressing the TLR4/MyD88/NF-κB pathway and inhibiting neutrophil extracellular trap formation.

Multifaceted evaluation of onion bio-actives against Fusarium oxysporum f.sp. Cubense: Bio-efficacy assay, LC-MS metabolomics and in-silico validation.

Polygonum cuspidatum Exosome-Like Nanovesicles Alleviate Hypoxic Pulmonary Hypertension by Stabilizing PON1 to Inhibit MAPK-Mediated PASMC Phenotypic Switching.

Correction: Pathogen effector tactics to suppress plant endomembrane system.

Single-nucleus transcriptomic data of susceptible and resistant tobacco stems after black shank infection.

Related Experiment Videos

Intravenous prostaglandin E1 in severe peripheral vascular disease

Related Concept Videos

Related Articles